Literature DB >> 11454713

High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.

A Ziegler1, M von Kienlin , M Décorps, C Rémy.   

Abstract

High-grade brain tumors are known to have a high rate of glucose (Glc) consumption. Postmortem measurements have suggested that Glc content in experimental brain tumors is relatively low. We used magnetic resonance spectroscopy to investigate this, in vivo, in the brains of seven rats bearing intracerebral C6 gliomas. We combined the high spectral resolution allowed by two-dimensional proton nuclear magnetic resonance with spatial encoding by magnetic field gradient pulses to obtain in vivo maps of Glc, alanine, hypotaurine, aspartate, phosphoethanolamine, Glu/Gln, N-acetylaspartate (NAA), phosphocreatine/creatine (PCr/Cr), choline-containing compounds, and lactate (Lac) (some of which are involved in energy metabolism). Compared with normal brain tissue, the main differences found in the gliomas were that Glc, NAA, PCr/Cr, and aspartate concentrations were much lower, whereas concentrations of alanine, hypotaurine, phosphoethanolamine, and Lac were higher, whatever the extent of necrosis. A striking observation is the similarity of the NAA and Glc images: the concentrations of both metabolites are lower in the tumor than they are in the contralateral brain. If Glc was completely absent from the tumor tissue, and if the residual Glc level was due only to a partial volume effect like that for NAA, a neuronal marker, the ratio [Glc]tumor/[Glc]contralateral tissue, should be similar to that found for NAA. The ratio for Glc was 0.48 +/- 0.22 (+/- SD; n = 6), a ratio similar to that found for PCr/Cr (0.50 +/- 0.19) but significantly higher than that obtained for NAA (0.29 +/- 0.07). This observation indicates that a measurable Glc concentration is still present in the tumor tissue. Intense glycolysis in tumor cells may explain the increased production of Lac and alanine and decreased amount of Glc. These nuclear magnetic resonance measurements of metabolite concentrations are complementary to positron emission tomography, which measures Glc consumption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454713

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Involvement of mitophagy in oncogenic K-Ras-induced transformation: overcoming a cellular energy deficit from glucose deficiency.

Authors:  June-Hyung Kim; Hee Young Kim; Young-Kyoung Lee; Young-Sil Yoon; Wei Guang Xu; Joon-Kee Yoon; Sung-E Choi; Young-Gyu Ko; Min-Jung Kim; Su-Jae Lee; Hee-Jung Wang; Gyesoon Yoon
Journal:  Autophagy       Date:  2011-10-01       Impact factor: 16.016

Review 2.  The Unwanted Cell Migration in the Brain: Glioma Metastasis.

Authors:  Xue Tao Qi; Jiang Shan Zhan; Li Ming Xiao; Lina Li; Han Xiao Xu; Zi Bing Fu; Yan Hao Zhang; Jing Zhang; Xi Hua Jia; Guo Ge; Rui Chao Chai; Kai Gao; Albert Cheung Hoi Yu
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

3.  Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics.

Authors:  J U Rao; U F H Engelke; F C G J Sweep; K Pacak; B Kusters; A G Goudswaard; A R M M Hermus; A R Mensenkamp; G Eisenhofer; N Qin; S Richter; H P M Kunst; H J L M Timmers; R A Wevers
Journal:  J Clin Endocrinol Metab       Date:  2014-12-02       Impact factor: 5.958

4.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.

Authors:  Ilwoo Park; Peder E Z Larson; Matthew L Zierhut; Simon Hu; Robert Bok; Tomoko Ozawa; John Kurhanewicz; Daniel B Vigneron; Scott R Vandenberg; C David James; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2010-01-25       Impact factor: 12.300

Review 5.  In vivo 2D magnetic resonance spectroscopy of small animals.

Authors:  P Méric; G Autret; B T Doan; B Gillet; C Sébrié; J-C Beloeil
Journal:  MAGMA       Date:  2004-12-29       Impact factor: 2.310

Review 6.  A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer.

Authors:  José M Cuezva; María Sánchez-Aragó; Sandra Sala; Amaya Blanco-Rivero; Alvaro D Ortega
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

7.  Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.

Authors:  Vassiliki Kostourou; Helen Troy; Joanne F Murray; Elizabeth R Cullis; Guy St J Whitley; John R Griffiths; Simon P Robinson
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

8.  Regulation and function of aquaporin-1 in glioma cells.

Authors:  Yasuhiko Hayashi; Nancy A Edwards; Martin A Proescholdt; Edward H Oldfield; Marsha J Merrill
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

9.  Free glycine accelerates the autoproteolytic activation of human asparaginase.

Authors:  Ying Su; Christos S Karamitros; Julian Nomme; Theresa McSorley; Manfred Konrad; Arnon Lavie
Journal:  Chem Biol       Date:  2013-04-18

10.  Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma.

Authors:  Rachel L Derr; Xiaobu Ye; Melissa U Islas; Serena Desideri; Christopher D Saudek; Stuart A Grossman
Journal:  J Clin Oncol       Date:  2009-01-12       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.